You are here

Federal laboratories are required by law to publish a notice of proposed exclusive licenses of available technologies. The purpose of the publication is to provide an opportunity for public comment. Comments generally must be received within 15 days from the publication date of the notice. Comments are submitted directly to the federal laboratory and will be reviewed accordingly.
E.g., Jun 25, 2022
E.g., Jun 25, 2022
Department of Veterans Affairs, Office of Research and Development (VA)
Jan 26, 2022

Systems and methods that combine an amplitude modulation spatial light modulator (SLM) with a phase modulating SLM in the same optical illumination system. The combination of the amplitude modulation SLM and the phase modulation SLM allows the optical illumination to compensate for the.[more]

Dept. of Veterans Affairs, Office of Research and Development (VA)
Jan 26, 2022

Systems and methods that combine an amplitude modulation spatial light modulator (SLM) with a phase modulating SLM in the same optical illumination system. The combination of the amplitude modulation SLM and the phase modulation SLM allows the optical illumination to compensate for the.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Jan 07, 2022

NOTICE: VA Offer of Exclusive Patent and Know-How License to UTECH Products Inc.

BY THE: Department of Veterans Affairs, Office of Research and Development (VA)

ON: January 6, 2021

SUMMARY: Notice is hereby given that the Department of Veterans Affairs (VA), Office of.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Dec 21, 2021

Real-Time Histology of Colonic Polyps with Augmented Visualization
Termed real-time histology (RTH), the method is an in situ Computer-Aided Diagnostic (CADx) approach that increases the transparency and interpretability of results by generating an intuitive augmented visualization of.[more]

Army Research Laboratory (ARL)
Nov 02, 2021

DEPARTMENT OF DEFENSE

Department of the Army

Notice of Intent to Grant Exclusive Patent License to Centimani, LLC; San Diego, CA

AGENCY: Department of the Army, DoD.

ACTION: Notice of Intent.
SUMMARY: The Department of the Army hereby gives notice of its.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Oct 15, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to LucyDx, LLC, 651 N. Broad St., Ste. 205 #4847, Middletown, DE 19709, USA, an exclusive license to international patent filing application no..[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Oct 04, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to SteroTherapeutics LLC, 3805 Old Easton Road Doylestown, Pennsylvania, 18902, USA, an exclusive license to international patent filing.[more]

U.S. Forest Service (FS) - Forest Products Laboratory (FPL)
Aug 26, 2021

Notice is hereby given that the U.S. Department of Agriculture, Forest Service, intends to grant to TAF Composites USA LLC, c/o Delaware Corporate Services Inc., Wilmington, Delaware, an exclusive license to U.S. Patent Application No. 15/896,265, “LIGNIN-BASED CARBON FOAMS AND COMPOSITES AND.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Aug 26, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to offer to Fillauer Companies, Inc., 210 Amnicola Highway, Chattanooga, TN 37406, an exclusive license to U.S. Patent Nos. 9,549,827; 10,105,243; 10,376,.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Aug 19, 2021

The present invention provides methods of treating an auditory impairment associated with outer hair cells of the cochlea in a subject. The method may comprise administering to said subject an effective amount of a composition comprising, as an active agent, an oligonucleotide sequence having a.[more]

Pages